Should we be using thromboprophylaxis to reduce risk of...

Should we be using thromboprophylaxis to reduce risk of venous thromboembolism in ambulatory lung cancer patients initiating chemotherapy?

Renninson, E., Hutchinson-Jones, N., Cox, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
139
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(20)30226-9
Date:
January, 2020
File:
PDF, 54 KB
2020
Conversion to is in progress
Conversion to is failed